Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Buy This Beaten-Down High-Yield Dividend Stock Before It's Too Late


The stock market has slowly started to come to its senses about telecom giant AT (NYSE: T). While the stock is still down significantly from its all-time high, shares have surged around 25% since they bottomed out in mid-2023.

Even after this rally, it's clear that a cloud of pessimism continues to hover over the stock. AT has a market capitalization of around $120 billion, and the company expects to generate between $17 billion and $18 billion of free cash flow this year. AT the midpoint of that range, AT stock trades for less than 7 times free cash flow.

The stock also looks inexpensive based on earnings. AT expects to report adjusted earnings per share between $2.15 and $2.25 in 2024, a number that will be reduced by an increase in depreciation and a few other items. The company's decision to invest $14 billion in Open RAN technology meant to transform its network requires it to depreciate existing equipment at a quicker rate, which will hurt earnings through 2026. Even so, at stock trades for less than 8 times the midpoint of its adjusted earnings guidance.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.046
4.600%
Allergy Therapeutics PLC dominated the market today, gaining €0.002 (4.600%).

Like: 0
T
Share

Comments